首站-论文投稿智能助手
典型文献
Antrodia cinnamomea exerts an anti-hepatoma effect by targeting PI3K/AKT-mediated cell cycle progression in vitro and in vivo
文献摘要:
Antrodia cinnamomea is extensively used as a traditional medicine to prevention and treat-ment of liver cancer.However,its comprehensive chemical fingerprint is uncertain,and the mechanisms,especially the potential therapeutic target for anti-hepatocellular carcinoma(HCC)are still unclear.Using UPLC-Q-TOF/MS,139 chemical components were identified in A.cinnamomea dropping pills(ACDPs).Based on these chemical components,network pharmacology demonstrated that the targets of active components were significantly enriched in the pathways in cancer,which were closely related with cell proliferation regulation.Next,HCC data was downloaded from Gene Expression Omnibus database(GEO).The Cancer Genome Atlas(TCGA)and DisGeNET were analyzed by bioinformatics,and 79 bio-markers were obtained.Furtherly,nine targets of ACDP active components were revealed,and they were significantly enriched in PI3K/AKT and cell cycle signaling pathways.The affinity between these targets and their corresponding active ingredients was predicted by molecular docking.Finally,in vivo and in vitro experiments showed that ACDPs could reduce the activity of PI3K/AKT signaling pathway and downregulate the expression of cell cycle-related proteins,contributing to the decreased growth of liver cancer.Altogether,PI3K/AKT-cell cycle appears as the significant central node in anti-liver cancer of A.Cinnamomea.
文献关键词:
作者姓名:
Yan Zhang;Pin Lv;Junmei Ma;Ning Chen;Huishan Guo;Yan Chen;Xiaoruo Gan;Rong Wang;Xuqiang Liu;Sufang Fan;Bin Cong;Wenyi Kang
作者机构:
Hebei Key Laboratory of Forensic Medicine,College of Forensic Medicine,Hebei Medical University,Shijiazhuang 050017,China;Hebei Food Safety Key Laboratory,Hebei Food Inspection and Research Institute,Shijiazhuang 050091,China;Cardiovascular Medical Science Center Department of Cell Biology,Hebei Medical University,Shijiazhuang 050017,China;National R&D Center for Edible Fungus Processing Technology,Henan University,Kaifeng 475004,China;Research Unit of Digestive Tract Microecosystem Pharmacology and Toxicology,Chinese Academy of Medical Sciences,Beijing 100730,China
引用格式:
[1]Yan Zhang;Pin Lv;Junmei Ma;Ning Chen;Huishan Guo;Yan Chen;Xiaoruo Gan;Rong Wang;Xuqiang Liu;Sufang Fan;Bin Cong;Wenyi Kang-.Antrodia cinnamomea exerts an anti-hepatoma effect by targeting PI3K/AKT-mediated cell cycle progression in vitro and in vivo)[J].药学学报(英文版),2022(02):890-906
A类:
ACDPs,ACDP,Cinnamomea
B类:
Antrodia,cinnamomea,exerts,anti,hepatoma,effect,by,targeting,PI3K,AKT,mediated,cycle,progression,vitro,vivo,extensively,used,traditional,medicine,prevention,treat,liver,cancer,However,its,comprehensive,chemical,fingerprint,uncertain,mechanisms,especially,potential,therapeutic,hepatocellular,carcinoma,HCC,are,still,unclear,Using,UPLC,TOF,components,were,identified,dropping,pills,Based,these,network,pharmacology,demonstrated,that,targets,active,significantly,enriched,pathways,which,closely,related,proliferation,regulation,Next,was,downloaded,from,Gene,Expression,Omnibus,database,GEO,Cancer,Genome,Atlas,TCGA,DisGeNET,analyzed,bioinformatics,markers,obtained,Furtherly,nine,revealed,they,signaling,affinity,between,their,corresponding,ingredients,predicted,molecular,docking,Finally,experiments,showed,could,reduce,activity,downregulate,expression,proteins,contributing,decreased,growth,Altogether,appears,central,node
AB值:
0.575517
相似文献
SNORA23 inhibits HCC tumorigenesis by impairing the 2?-O-ribose methylation level of 28S rRNA
Zhiyong Liu;Yanan Pang;Yin Jia;Qin Qin;Rui Wang;Wei Li;Jie Jing;Haidong Liu;Shanrong Liu-Department of Laboratory Diagnostics,Changhai Hospital,Second Military Medical University,Shanghai 200433,China;Department of Gastroenterology and Hepatology,Zhongshan Hospital,Fudan University,Shanghai 200032,China;Department of Gastroenterology,Changhai Hospital,Second Military Medical University,Shanghai 200433,China;Shanghai Institute of Pancreatic Diseases,Shanghai 200433,China;Department of Chemistry and State Key Laboratory of Molecular Engineering of Polymers,Fudan University,Shanghai 200433 China;Department of General Surgery,Changzheng Hospital,Second Military Medical University,Shanghai 200433,China;Shanghai Fourth People's Hospital,Tongji University School of Medicine,Shanghai 200081,China
Efficacy of rigosertib, a small molecular RAS signaling disrupter for the treatment of KRAS-mutant colorectal cancer
Xinyi Zhou;Qian Xiao;Dongliang Fu;Haochen Zhang;Yang Tang;Jinjie He;Yeting Hu;Xiangxing Kong;Fei Teng;Xiangrui Liu;Ying Yuan;Kefeng Ding-Department of Colorectal Surgery and Oncology,Key Laboratory of Cancer Prevention and Intervention,Ministry of Education,the Second Affiliated Hospital of Zhejiang University School of Medicine,Hangzhou 310009,China;Department of Medical Oncology,Key Laboratory of Cancer Prevention and Intervention,Ministry of Education,the Second Affiliated Hospital of Zhejiang University School of Medicine,Hangzhou 310009,China;Hangzhou Oncocare Co Ltd,Hangzhou 310009,China;Department of Pharmacology,Zhejiang University School of Medicine,Hangzhou 310058,China;Cancer Center,Zhejiang University,Hangzhou 310009,China
Overexpressed NEDD8 as a potential therapeutic target in esophageal squamous cell carcinoma
Jingrong Xian;Shiwen Wang;Yanyu Jiang;Lihui Li;Lili Cai;Ping Chen;Yue Liu;Xiaofei Zeng;Guoan Chen;Chen Ding;Robert M.Hoffman;Lijun Jia;Hu Zhao;Yanmei Zhang-Department of Laboratory Medicine,Huadong Hospital Affiliated to Fudan University,Shanghai 200040,China;Cancer Institute,Longhua Hospital,Shanghai University of Traditional Chinese Medicine,Shanghai 200032,China;Research Center on Aging and Medicine,Fudan University,Shanghai 200040,China;Shanghai Key Laboratory of Clinical Geriatric Medicine,Shanghai 200040,China;Department of Basic Science of Oncology,College of Basic Medical Sciences,Zhengzhou University,Collaborative Innovation Center of Henan Province for Cancer Chemoprevention,Zhengzhou 450001,China;School of Medicine,Southern University of Science and Technology,Shenzhen 518055,China;State Key Laboratory of Genetic Engineering,Human Phenome Institute,Institutes of Biomedical Sciences,School of Life Sciences,Zhongshan Hospital,Fudan University,Shanghai 200032,China;State Key Laboratory of Cell Differentiation and Regulation,Henan International Joint Laboratory of Pulmonary Fibrosis,Henan Center for Outstanding Overseas Scientists of Pulmonary Fibrosis,College of Life Science,Institute of Biomedical Science,Henan Normal University,Xinxiang 453007,China;Department of Surgery,University of California,San Diego 92101,USA;Anticancer Inc.,San Diego 92101,USA
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。